Structures of langya virus fusion protein ectodomain and immunogenic compositions derived therefrom
US-2024358817-A1 · Oct 31, 2024 · US
US2021255107A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2021255107-A1 |
| Application number | US-202117198816-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 11, 2021 |
| Priority date | Mar 15, 2013 |
| Publication date | Aug 19, 2021 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides systems for characterizing a biological sample by analyzing emission of fluorescent light from the biological sample upon excitation and methods for using the same. The system includes a laser source, collection fibers, a demultiplexer and an optical delay device. All references cited herein are incorporated by reference in their entirety as though fully set forth. Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of-ordinary skill in the art in which this invention belongs.
Opening claim text (preview).
1 . A system for characterizing a biological sample by analyzing emission of fluorescent light from the biological sample upon excitation comprising: (a) a laser source connected to a biological sample via excitation fibers (ExF), wherein the laser is configured to irradiate the biological sample with a laser pulse at a predetermined wavelength to cause the biological sample to produce a responsive fluorescence signal; (b) a light collector, wherein the light collector collects the responsive fluorescence signal from the biological sample, and relays the fluorescence signal to a plurality of filters; and (c) the plurality of filters, each filter of the plurality of filters being configured to split the responsive fluorescence signal at pre-determined wavelengths to obtain spectral bands, wherein a first spectral band comprises wavelengths within a range of 410-450 nm, a second spectral band comprises wavelengths within a range of 450-480 nm, and a third spectral band comprises wavelengths within a range of 500-560 nm. 2 . The system of claim 1 , wherein a fourth spectral band comprises wavelengths within a range of 365-410 nm and wherein a fifth spectral band comprises wavelengths greater than 600 nm, and optionally wherein a sixth spectral band comprises wavelengths of less than 365 nm. 3 . The system of claim 1 , further comprising an optical delay device. 4 . The system of claim 3 , wherein the optical delay device is adapted to couple the spectral bands from the plurality of filters into the optical delay device, allow the spectral bands to travel through the optical delay device, and introduce a controlled time delay to the spectral bands as the spectral bands travel through the optical delay device. 5 . The system of claim 3 , wherein the optical delay device comprises a plurality of optical fibers and optionally wherein two or more of the plurality of optical fibers have different optical path lengths. 6 . The system of claim 1 , wherein the plurality of filters form a demultiplexer. 7 . The system of claim 1 , wherein the light collector comprises one or more collection fibers (CF) or lenses. 8 . A method for characterizing a biological sample by analyzing emission of a fluorescence signal from the biological sample upon excitation comprising: (a) irradiating the biological sample with a laser pulse at a predetermined wavelength to cause the biological sample to produce a responsive fluorescence signal; (b) collecting the responsive fluorescence signal from the biological sample; and (c) splitting the responsive fluorescence signal with a plurality of filters, each filter of the plurality of filters being configured to split the responsive fluorescence signal at pre-determined wavelengths to obtain spectral bands, wherein a first spectral band comprises wavelengths within a range of 410-450 nm, a second spectral band comprises wavelengths within a range of 450-480 nm, and a third spectral band comprises wavelengths within a range of 500-560 nm. 9 . The method of claim 8 , wherein a fourth spectral band comprises wavelengths within a range of 365-410 nm and wherein a fifth spectral band comprises wavelengths greater than 600 nm, and optionally wherein a sixth spectral band comprises wavelengths of less than 365 nm. 10 . The method of claim 8 , wherein the responsive fluorescence signal is emitted by a biomolecule and optionally wherein the biomolecule is any one or more of PLP-GAD (pyridoxal-5′-phosphate (PLP) glutamic acid decarboxylase (GAD)), bound NADH, free NADH, flavin mononucleotide (FMN) riboflavin, flavin adenine dinucleotide (FAD) riboflavin, lipopigments, endogenous porphyrins or a combination thereof. 11 . A method for determining tissue viability comprising analyzing emission of responsive fluorescence signals from biomolecules in the tissue by the method of claim 8 , wherein an increase in responsive fluorescence signals of the biomolecule in the biological sample relative to a normal sample is indicative of poor tissue viability. 12 . A method for continuously monitoring cellular metabolism comprising analyzing emission of a responsive fluorescence signal by the method of claim 8 . 13 . A method for determining drug or metabolite level in plasma comprising analyzing emission of a responsive fluorescence signal from a biomolecule by the method of claim 8 . 14 . The method of claim 8 , further comprising (d) passing the spectral bands through a time-delay mechanism; (e) obtaining the time-delayed spectral bands; and (f) processing the time-delayed spectral bands. 15 . The method of claim 14 , wherein processing the time-delayed spectral bands comprises detecting the time-delayed spectral bands.
using optical fibers · CPC title
invasive, e.g. introduced into the body by a catheter · CPC title
Fluorescence spectrometry · CPC title
for introduction into the body, e.g. by catheters (A61B5/1459 takes precedence) · CPC title
Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.